Pre-Conference Workshop

How Innovation Impacts in Personalized Medicine

Moderator: Regina Oliveira, Universidade Federal de São Carlos-UFSCar; Leila Maria Lopes Bezerra, BIDiagnostics / CIETEC / USP

9:00 AM - 12 NOON
Drug R&D in a Multi-Omic World: Present and Future

Workshop Leader: Regina Oliveira, Universidade Federal de São Carlos - UFSCar

The Age of Proteomics in Clinical Diagnostics
Valdemir Melechco Carvalho, Instituto Fleury

O Impacto das Células Tronco no Processo de Descoberta de Fármacos
Marcos Valadares, Pluricell Biotech

Targeted Metabolomics Applications for Cancer and Cardiovascular Biomarkers Discovery
Amadeu Iglesias, Apex Science

Human Microbiome Impacts on Host Health and the Role of Omics Platforms
Elisa Haas, Instituto do Coração (INCOR- HCFMUSP)

2:00 PM - 5:00 PM
The Innovation Era in Medical Diagnostics

Workshop Leader: Leila Lopes Bezzera, BIDiagnostics / CIETEC / USP

Inovações em Genômica Pessoal e Medicina Personalizada
Ricardo di Lazzaro, Genera/Dasa

Implantation and Development of Rapid Test for STEC and ETEC Detection
Letícia Barboza Rocha, Instituto Butantã

Testes Rápido: Conceitos Básicos, Aplicações e Evolução da Technologica
Ana Luísa Rubert Barcelos, Wama Diagnóstica

An Educative Experience Aiming Innovation in Biomedicine at the University of São Paulo
Luis Carlos Ferreira, ICB/USP

(NOTE: This workshop is not held at Espaço Citron)

Pre-Conference Workshop

Sponsored by SCIEX

SCIEX Brasil is pleased to invite you to be part of the CPSA Brazil Pre-Conference 2019 workshop

The meeting will address Pharmaceuticals, focusing on Degradation and it will be a great opportunity for you learn new ways to improve your search, and exchange experiences.

Download workshop invitation

RSVP to marketing.br@sciex.com

(NOTE: This workshop is not held at Espaço Citron)

Registration

Coffee and Continental Breakfast

Welcome & Opening Remarks

Opening Remarks - Together We Progress

Plenary Lecture

CPSA BRASIL Expo

Meet and mingle with our participating vendors.

Symposium Session 1

Early-Phase Product Development:
What Have We Got and What Are the Challenges

Chairs: Sônia Dainesi, ReceptaBio; Gustavo M. L. Santos, ANVISA

DDCM preparation: Challenges When the Drug is Still in Early-phase of Development
Claudia Cilento, Inovatie

New Designs for RCTs: Adaptative Bayesian Studies, Platform Trials and Enrichment
Alexandre Biasi Cavalcanti, Research Institute, HCor

Real World Data: Is This Really Real? Is RWD Applicable in Early-phase of Development?
Guilherme Julian, IQVIA/RWE

Sponsored Lunch & Roundtables

To Be Announced

Sponsored by Nova Analítca

Chairs: Luiz Bravo, Nova Analitíca; Carlos Kiffer, EPM / UNIFESP

Jabuticaba Session 1

Early-Phase and Pre-Clinical Product Development: How Far Have We Matured our R&D Ecosystem and What Are the Challenges

Chair: Jose Donato, Vita Nova

When Pre-Clinical Trials Are Not Necessary for Drug Development
Gilberto De Nucci, University of São Paulo

ADMETox Assessment in Human Organoids Cultivated in Microfluidic Chips (Organ on a Chip)
Shining a New Light on Brazilian Biodiversity: Using the New Brazilian Synchrotron Light Source for Drug Discovery.
Eduardo Pagani, LNBio - Brazilian Biosciences National Laboratory

Pharmacometrics: Modelling and Simulation Tools to Facilitate the Integration of Preclinical and Clinical Development Data
Bruna Gaelzer Silva Torre, Instituto Vitanova

Jabuticaba Session 2

Challenges to Transpose from Bench to Business in Biomedical Science

Chairs: Regina Oliveira, Universidade Federal de São Carlos - UFSCar; Leila Lopes Bezerra, BIDiagnostics

Biolinker: Building a Biotech Startup in Brazil
Mona das Neves Oliveira, Biolinker

BIDiagnostics Case: Product to Market
Leila Lopes Bezerra, BIDiagnostics

Overcoming Challenges in Quantitation of Biopharmaceuticals with Hybrid Techniques
Regina Oliveira, UFSCar

Entrepreneurial Science: From Laboratory to Market
Guilherme Rosso, Emerge Labs

Vendor Session

Chair: Daniel Maturana, NanoTemper

Participating vendors are welcome to share their services, products, and corporate message within a 5-minute presentation.

Registration

Coffee and Continental Breakfast

Plenary Lecture

Symposium Session 2

Early-Phase Product Development: What Are the Technological Challenges and How Can the Academia-Industry Relationship Improve

Chair: Rogério Sassonia, Universidade Federal do Tocantins -Araguaín

Opportunities of Public Funds to Research, Development and Innovation
Lucas Aquino, IDR Consultoria

Strategic Positioning of Medical Sciences as Foundation for Innovation
Maíra Simões, Johnson & Johnson

Challenges and Benefits of Research Projects with Funding Agencies: Viewpoint of a Startup
Peky Noriega, Nanofitotec

CPSA BRASIL Expo

Meet and mingle with our participating vendors.

Sponsored Lunch & Roundtables

From Invention to Innovation

Sponsored by New Objective

Carlos Kiffer, EPM / UNIFESP

Jabuticaba Session 3

Late and Clinical Phase Development: Progresses and Drawbacks of the Regulated Research

Chair: Gustavo Santos, ANVISA

Jabuticaba Session 4

What Are the Big Problems Now in the Development or Production of the Pharmaceutical Industry?

Chair: Daniel Lebre, CEMSA; Daniel Maturana, NanoTemper Technologies

Building Bioeconomies in the U.S. and Brazil: Confluence, Disjuncture, and Prospects for International Collaboration
Tess Doezema, Arizona State University

Adding Some Intelligence into the Operations of Brazilian Pharma Industry: Practical Cases
Rafael A. Barrientos

Forming a Radical Innovation Ecosystem in Brazil through Research Platforms and Strategic Partnerships
Hatylas Felype Zaneti de Azevedo, Ache Laboratórios Farmacêuticos S/A

ANNOUNCEMENTS, Awards & Closing Remarks

Founder Awards
Mike Lee, Milestone Development Services & Carlos Kiffer, EPM/UNIFESP

Program Chair Recognition
Mike Lee, Milestone Development Services

Closing Remarks
Carlos Kiffer, EPM/UNIFESP
Mike Lee, Milestone Development Services